Skip to main content
. 2019 Sep 23;18:325. doi: 10.1186/s12936-019-2950-4

Table 2.

Clinical outcomes aggregated by drug treatment (%)

Clinical outcome (%) PCR results ASMQ CQ AL Overall
Related relapse Homologous 6 66.7% 6 80.0% 8 84.6% 20 77.1%
Similar 2 2 3 7
Reinfections or unrelated hypnozoites’ activation Heterologous 4 33.3% 2 20.0% 2 15.4% 8 22.9%
Overall 12 10 13 35